Wire · technology
AI may have cracked the antiaging code
◆ Sectors
◆ Source
◆ Verified
Fusion42 · 16 September 2026 · Fusion42 review
A pharmaceutical company, Insilico Medicine, has used AI to discover a drug, rentosertib, that may slow the aging process by reducing biological markers of age. This AI-assisted drug discovery marks a significant step in accelerating drug development, though the small trial size and limited testing mean its broader effectiveness and safety remain uncertain.
This Wire brief sits within Fusion42's coverage of AI Frontier Models, Drug Discovery and Biotech, and 4 sources have reported it between 8 Sep 2026 and 16 Sep 2026.
◆ ◆ The Wire takeaway
You face a faster path from concept to clinical trial as AI reshapes drug discovery, especially for novel areas like antiaging. This creates an opening to innovate drug candidates with less reliance on traditional lab testing early on.
◆ Coverage
4 sources · first reported 8 Sep 2026 · latest 16 Sep 2026
◆ Related on Wire
◆ Topics